NCT06812442Completed
Effectiveness of a 3-month Individual Reminiscence Therapy Program in Older Adults With Alzheimer's Disease
Effectiveness of a 3-month Individual Reminiscence Therapy Program on Global Cognition, Mood, and Quality of Life in Older Adults With Mild to Moderate Alzheimer's Disease: A Multicenter Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 28 May 2025
Brief summary (registry, in English)
This research aims to evaluate the effectiveness of individual Reminiscence Therapy (RT) program, using a simple reminiscence format, to improve the overall cognitive function, mood, and quality of life (QoL) of older adults with mild to moderate Alzheimer's disease attending social care and support services. A multicentre randomised controlled trial (RCT) is proposed in Portugal with repeated measures (pre-intervention, and post-intervention). Intervention group will hold 26 individual RT sessions, twice a week for 13 weeks. Control group participants will maintain their treatment as usual. Make a subsample analysis of the main clinical diagnoses, and compare the results of sample and subsample with a previous study that had the same intervention protocol.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 2 Feb 2025
- Start date
- 1 Feb 2025
- Primary completion date
- 23 May 2025
- Lead sponsor
- Rsocialform - Geriatria, Lda
- Diseases
- Alzheimer disease
- NCT number
- NCT06812442
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 1 Feb 2025 to the primary completion date, 23 May 2025
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Acute or serious illness precluding participation in the RT sessions.
Other
- Severe sensory and physical limitations.
- Evidence of aggressive and disruptive behaviour, as observed by staff at the facility.
- Starting neuroleptics or antipsychotics within two months of recruitment.
- No literacy (educational level).
Who the study is looking for
- 65 years or older.
- Receiving care and support services for at least three months.
- Diagnosis of probable Alzheimer's disease according to Diagnostic and Statistical Manual of Mental Disorders (DSM), fifth edition text revision criteria.
- Intact communication skills.
- Native Portuguese speaking.
- Signed informed consent by the participant.
- Mini Mental State Examination (MMSE) score between 10 and 24 points
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centro Social Remelhe D. António Barroso Coordinator of this site? Confirm its status | Barcelos | Portugal | Unknown status |
| Fundação João Bento Raimundo Coordinator of this site? Confirm its status | Guarda | Portugal | Unknown status |
| Centro Social e Paroquial de Brinches Coordinator of this site? Confirm its status | Serpa | Portugal | Unknown status |
| Associação de Socorros da Freguesia Turcifal Coordinator of this site? Confirm its status | Torres Vedras | Portugal | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.